In recent years it has been supposed that impaired intestinal permeability represents an early event preceding the onset of inflammatory bowel disease (IBD). Since zonulin has been proposed as a biomarker of intestinal permeability, we investigated its role in patients with IBD and the correlation between serum and fecal zonulin.

Serum zonulin in patients with inflammatory bowel disease: a pilot study

Caviglia, Gian Paolo;DUGHERA, FRANCESCA;Ribaldone, Davide G;Rosso, Chiara;Abate, Maria L;Pellicano, Rinaldo;Smedile, Antonina;Saracco, Giorgio M;
2019

Abstract

In recent years it has been supposed that impaired intestinal permeability represents an early event preceding the onset of inflammatory bowel disease (IBD). Since zonulin has been proposed as a biomarker of intestinal permeability, we investigated its role in patients with IBD and the correlation between serum and fecal zonulin.
MINERVA MEDICA
110
95
100
Caviglia, Gian Paolo; Dughera, Francesca; Ribaldone, Davide G; Rosso, Chiara; Abate, Maria L; Pellicano, Rinaldo; Bresso, Francesca; Smedile, Antonina; Saracco, Giorgio M; Astegiano, Marco
File in questo prodotto:
File Dimensione Formato  
Minerva Med-5787_Manoscritto_V1_2018-07-16.pdf

accesso aperto

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 202.26 kB
Formato Adobe PDF
202.26 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/1679752
Citazioni
  • ???jsp.display-item.citation.pmc??? 23
  • Scopus 44
  • ???jsp.display-item.citation.isi??? 40
social impact